ACSL1
Long-chain-fatty-acid--CoA ligase 1
Also known as: ACS1, ACSL1_HUMAN, FACL1, FACL2, LACS, LACS1, LACS2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P33121
- Gene
- ACSL1
- Ensembl
- ENSG00000151726
- Chromosome
- 4
- Canonical length
- 698 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
The protein encoded by this gene is an isozyme of the long-chain fatty-acid-coenzyme A ligase family. Although differing in substrate specificity, subcellular localization, and tissue distribution, all isozymes of this family convert free long-chain fatty acids into fatty acyl-CoA esters, and thereby play a key role in lipid biosynthesis and fatty acid degradation. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013]
Canonical amino-acid sequenceUniProt
698 residues, UniProt reviewed canonical sequence.
>P33121|ACSL1
1 MQAHELFRYF RMPELVDFRQ YVRTLPTNTL MGFGAFAALT TFWYATRPKP LKPPCDLSMQ
61 SVEVAGSGGA RRSALLDSDE PLVYFYDDVT TLYEGFQRGI QVSNNGPCLG SRKPDQPYEW
121 LSYKQVAELS ECIGSALIQK GFKTAPDQFI GIFAQNRPEW VIIEQGCFAY SMVIVPLYDT
181 LGNEAITYIV NKAELSLVFV DKPEKAKLLL EGVENKLIPG LKIIVVMDAY GSELVERGQR
241 CGVEVTSMKA MEDLGRANRR KPKPPAPEDL AVICFTSGTT GNPKGAMVTH RNIVSDCSAF
301 VKATENTVNP CPDDTLISFL PLAHMFERVV ECVMLCHGAK IGFFQGDIRL LMDDLKVLQP
361 TVFPVVPRLL NRMFDRIFGQ ANTTLKRWLL DFASKRKEAE LRSGIIRNNS LWDRLIFHKV
421 QSSLGGRVRL MVTGAAPVSA TVLTFLRAAL GCQFYEGYGQ TECTAGCCLT MPGDWTAGHV
481 GAPMPCNLIK LVDVEEMNYM AAEGEGEVCV KGPNVFQGYL KDPAKTAEAL DKDGWLHTGD
541 IGKWLPNGTL KIIDRKKHIF KLAQGEYIAP EKIENIYMRS EPVAQVFVHG ESLQAFLIAI
601 VVPDVETLCS WAQKRGFEGS FEELCRNKDV KKAILEDMVR LGKDSGLKPF EQVKGITLHP
661 ELFSIDNGLL TPTMKAKRPE LRNYFRSQID DLYSTIKVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACSL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 1,069 nTPM
Expression across tissuesHPA
Tissue
- liver: 1,069 nTPM
- skeletal muscle: 697 nTPM
- adipose tissue: 680 nTPM
- tongue: 397 nTPM
- breast: 321 nTPM
- bone marrow: 238 nTPM
Single-cell type
- neutrophils: 13,299 nCPM
- monocytes: 2,703 nCPM
- hepatocytes: 1,379 nCPM
- adipocytes: 1,335 nCPM
- neutrophil progenitors: 1,214 nCPM
- monocyte progenitors: 945 nCPM
Immune cell
- neutrophil: 456 nTPM
- classical monocyte: 53 nTPM
- intermediate monocyte: 30 nTPM
- non-classical monocyte: 21 nTPM
- total PBMC: 20 nTPM
- eosinophil: 17 nTPM
Brain region
- white matter: 117 nTPM
- thalamus: 106 nTPM
- medulla oblongata: 106 nTPM
- cerebral cortex: 98 nTPM
- choroid plexus: 93 nTPM
- pons: 82 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.48
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.4
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adiponectin-activated signaling pathway
- fatty acid biosynthetic process
- fatty acid transport
- linoleic acid metabolic process
- lipid biosynthetic process
- long-chain fatty acid import into cell
- long-chain fatty acid metabolic process
- long-chain fatty-acyl-CoA biosynthetic process
- positive regulation of cold-induced thermogenesis
- positive regulation of long-chain fatty acid import across plasma membrane
- response to nutrient
- triglyceride biosynthetic process
- very long-chain fatty acid metabolic process
- xenobiotic catabolic process
- response to oleic acid
Molecular functions
- arachidonate-CoA ligase activity
- ATP binding
- long-chain fatty acid-CoA ligase activity
- oleoyl-CoA ligase activity
- palmitoyl-CoA ligase activity
- phytanate-CoA ligase activity
- pristanate-CoA ligase activity
- protein serine/threonine kinase activator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACSL1 as an antibody target. Whether an autoantibody or antibody against ACSL1 could matter depends on whether native ACSL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACSL1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ACSL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...